Risk Calculator 3 + DRE
Risk Calculator 3 + DRE assessment predicts more accurately the chance of a positive sextant biopsy for a man who has never been screened, compared to only assessing his PSA value (RC 2); without the necessity of a TRUS. An additional feature is the prediction of a high grade or advanced prostate cancer.